Patent · US Active

Method of assessing growth hormone deficiency in humans by a macimorelin containing composition

US10288629B1 · kind B1 · utility

1Cited by
3References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 30, 2018
Grant dateMay 14, 2019
Priority date
Expiry dateMay 30, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/048
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides a method for measuring growth hormone level in a human or animal subject, including a method of assessing pituitary-related growth hormone deficiency in a human or animal subject, after macimorelin oral administration to the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.